disulfiram has been researched along with buprenorphine in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 6 (50.00) | 29.6817 |
| 2010's | 5 (41.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wodak, A | 1 |
| Carroll, KM; Chawarski, MC; George, TP; Kosten, TR; Pakes, J; Schottenfeld, RS | 1 |
| Bailey, KP | 1 |
| Garnick, DW; Hodgkin, D; Horgan, CM; Merrick, EL; Reif, S | 1 |
| Kassed, CA; Kranzler, HR; Levit, KR; Mark, TL; Vandivort-Warren, R | 1 |
| Chand, PK; Thirthalli, J | 1 |
| Abraham, AJ; Knudsen, HK; Roman, PM | 1 |
| Douaihy, AB; Kelly, TM; Sullivan, C | 1 |
| Cummings, GR; Heinrich, CJ | 1 |
| Chawarski, MC; Cubells, JF; George, TP; Kosten, TR; Lappalainen, J; Schottenfeld, RS | 1 |
| Friedmann, PD; Park, TW | 1 |
5 review(s) available for disulfiram and buprenorphine
| Article | Year |
|---|---|
Managing illicit drug use. A practical guide.
Topics: Buprenorphine; Counseling; Disulfiram; Humans; Methadone; Methadyl Acetate; Naltrexone; Psychotherapy; Self-Help Groups; Substance Abuse Treatment Centers; Substance-Related Disorders | 1994 |
Pharmacological treatments for substance use disorders.
Topics: Adrenergic beta-Antagonists; Alcohol Deterrents; Anti-Anxiety Agents; Benzodiazepines; Buprenorphine; Disulfiram; Humans; Methadone; Naltrexone; Narcotic Antagonists; Narcotics; Neurobiology; Neuropharmacology; Psychopharmacology; Substance Withdrawal Syndrome; Substance-Related Disorders | 2004 |
The implications of medication development in the treatment of substance use disorders in developing countries.
Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Buprenorphine; Comorbidity; Developing Countries; Disulfiram; HIV Infections; Humans; Methadone; Narcotic Antagonists; Prevalence; Public Policy; Substance Abuse, Intravenous; Substance-Related Disorders; Taurine | 2009 |
Medications for substance use disorders.
Topics: Alcohol Deterrents; Alcoholism; Analgesics, Opioid; Behavior Therapy; Behavior, Addictive; Buprenorphine; Disulfiram; Humans; Naltrexone; Narcotic Antagonists; Secondary Prevention; Smoking Cessation; Substance Withdrawal Syndrome; Substance-Related Disorders; Tobacco Use Disorder | 2013 |
Medications for addiction treatment: an opportunity for prescribing clinicians to facilitate remission from alcohol and opioid use disorders.
Topics: Acamprosate; Analgesics, Opioid; Behavior, Addictive; Buprenorphine; Directive Counseling; Disulfiram; Humans; Methadone; Naltrexone; Narcotic Antagonists; Practice Patterns, Physicians'; Substance-Related Disorders; Taurine; United States | 2014 |
2 trial(s) available for disulfiram and buprenorphine
| Article | Year |
|---|---|
Disulfiram versus placebo for cocaine dependence in buprenorphine-maintained subjects: a preliminary trial.
Topics: Adult; Alcohol Deterrents; Buprenorphine; Chi-Square Distribution; Cocaine-Related Disorders; Disulfiram; Female; Heroin Dependence; Humans; Male; Narcotic Antagonists; Substance Abuse Detection; Time Factors | 2000 |
Randomized clinical trial of disulfiram for cocaine dependence or abuse during buprenorphine treatment.
Topics: Adolescent; Adult; Alcohol Deterrents; Alcoholism; Alleles; Buprenorphine; Cocaine-Related Disorders; Data Interpretation, Statistical; Disulfiram; DNA; Double-Blind Method; Drug Therapy, Combination; Female; Genotype; Humans; Male; Middle Aged; Narcotic Antagonists; Opioid-Related Disorders; Pharmacogenetics; Polymerase Chain Reaction; Sample Size; Treatment Outcome; Young Adult | 2014 |
5 other study(ies) available for disulfiram and buprenorphine
| Article | Year |
|---|---|
Disulfiram and buprenorphine for treating cocaine addiction.
Topics: Buprenorphine; Cocaine-Related Disorders; Disulfiram; Humans | 2000 |
Availability of addiction medications in private health plans.
Topics: Alcohol Deterrents; Alcoholism; Buprenorphine; Cost Sharing; Data Collection; Disulfiram; Drugs, Generic; Formularies as Topic; Health Services Accessibility; Humans; Insurance Coverage; Insurance, Pharmaceutical Services; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; United States | 2008 |
Alcohol and opioid dependence medications: prescription trends, overall and by physician specialty.
Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Buprenorphine; Delayed-Action Preparations; Disulfiram; Drug Costs; Drug Prescriptions; Drug Therapy, Combination; Drug Utilization; Humans; Naltrexone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Osteopathic Medicine; Physicians; Physicians, Family; Psychiatry; Taurine; United States | 2009 |
Using medication-assisted treatment for substance use disorders: evidence of barriers and facilitators of implementation.
Topics: Acamprosate; Alcohol Deterrents; Buprenorphine; Disulfiram; Humans; Naltrexone; Narcotic Antagonists; Patient Education as Topic; Substance Abuse Treatment Centers; Substance-Related Disorders; Taurine; United States | 2011 |
Adoption and diffusion of evidence-based addiction medications in substance abuse treatment.
Topics: Alcohol Deterrents; Buprenorphine; Diffusion of Innovation; Disulfiram; Evidence-Based Medicine; Health Services Research; Humans; Naltrexone; Narcotic Antagonists; Practice Patterns, Physicians'; Substance Abuse Treatment Centers; Substance-Related Disorders; Surveys and Questionnaires; United States | 2014 |